Breast Reconstruction Surgery and Treatment Market By 2023 to 2033: Innovation and Development

BySanket Badgujar
Breast Reconstruction Surgery and Treatment Market

The global breast reconstruction surgery and treatment market is anticipated to amass a revenue of USD 1.61 billion in 2033, rising from an estimated USD 901.3 million in 2023. The market is set to grow at a moderate and restored CAGR of 5.9% from 2023 to 2033. Historically, the market for breast reconstruction surgery and treatment recorded a CAGR of 4.6% and arrived at a value of USD 853.9 million in 2022. An upsurge in the cases of breast cancer, a rise in the number of breast reconstruction procedures, and a growth in the demand for acellular dermal matrix will facilitate the expansion of the breast reconstruction surgery and treatment market in the upcoming years.

Recent developments and improvements in breast reconstruction techniques have enhanced the accuracy of implant positioning while lessening the recovery period and discomfort. This has a positive influence on the breast reconstruction surgery and treatment market. The rising adoption of the acellular dermal matrix (ADMs) will generate greater opportunities than breast implants as a result of the incorporation of advancing technology. This factor will further propel the breast reconstruction surgery and treatment market over the next couple of years.

Get Sample Report Visit: https://www.futuremarketinsights.com/reports/sample/rep-gb-14393

The high prevalence of breast cancer creates greater demand for breast reconstruction surgery and treatment market as, often, after a mastectomy, many women opt for breast reconstruction surgery. While some women avoid getting breast reconstruction surgery due to either a lack of awareness or other health issues, the number of women who do have the surgery is rising. Thus, growing cases of breast cancer and the rising number of breast reconstruction surgery will bolster the growth of the breast reconstruction surgery and treatment market. Further, the emergence of 3D-printed prosthetics and implants as well as surging research and development efforts in the field will augur well for the development of the breast reconstruction surgery and treatment market.

Key Takeaways:

  • Availability of alternatives like non-surgical methods and a general lack of awareness regarding the treatment options may limit the growth of the breast reconstruction surgery and treatment market.
  • By product, the tissue expanders segment will account for 64.5% of the market share during 2023 and 2033.
  • Based on procedures, the immediate procedure category will dominate the market with a revenue share of 30.1%.
  • The US breast reconstruction surgery and treatment market will likely hold a market share of 32.0% in 2023 owing to the increasing number of breast augmentation operations.
  • China’s breast reconstruction surgery and treatment market will record a CAGR of 3.3% due to the high incidence of breast cancer and a rise in the awareness of treatment options.

Competitive Landscape:

GC Aesthetics, Establishment Labs S.A., Mentor Worldwide LLC (Johnson & Johnson), Allergan Aesthetics (An AbbVie Company), and Sientra, among others, are some of the key players in the breast reconstruction surgery and treatment market profiled in the full version of the report.

Leading market players are focusing on the geographical expansion of business and the launch of new products. These enterprises also employ strategic partnerships, collaborations, mergers, and acquisitions to enhance their market footprints.

Key Segments Covered in Breast Reconstruction Surgery and Treatment Industry Research:

Product:

  • Breast Implants
    • Silicone Implants
    • Saline Implants
  • Tissue Expanders
  • Acellular Dermal Matrix

Procedure:

  • Immediate
  • Delayed
  • Revision

Surgery:

  • Unilateral
  • Bilateral

End-User:

  • Hospitals
  • Cosmetology Clinics and Ambulatory Surgical Centers

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)